Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The UK Biobank imaging sub-study enables large-scale measurement of pancreas volume, an important biomarker in metabolic disease, including diabetes. Previous methods utilised a pancreas-specific (PS) 3D MRI UK Biobank acquisition to automatically measure pancreas volume. This may lead to a clinically significant underestimation of volume, due to partial coverage of the pancreas in these acquisitions. To address this, we propose a pipeline for the accurate measurement of pancreas volume using stitched whole-body (WB) 3D MRI UK Biobank acquisitions and deep learning-based segmentation. We implement and compare the performance of six different U-Net-like model architectures, leveraging attention layers, recurrent layers, and residual blocks. Furthermore, we investigate pancreas volumetry in 42,313 subjects, separated by sex, and present novel results concerning the change in pancreas volume throughout the course of a day (diurnal variation). To the best of our knowledge, this is the largest pancreas volumetry study to date and the first to propose a pipeline using the whole-body UK Biobank MRI acquisitions to measure pancreas volume.

Original publication

DOI

10.1007/978-3-030-80432-9_21

Type

Conference paper

Publication Date

01/01/2021

Volume

12722 LNCS

Pages

265 - 279